DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-72.28%
US · US
FDS.US latest organized financial period shows revenue lacks a complete YoY comparison and net income grew +11.15% YoY. Current price is about 231 USD, while the model base case is about 302 USD; the current price sits -23.5% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:28
Hover each model row to inspect formulas and inputs.
-23.51%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
-72.28%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
-48.16%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly -1.5% annualized FCF growth.
Estimates earnings power value without assuming growth.
+45.82%
Updated: 2026/04/29 15:28
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/08/31 | Business sale gain/loss | Asset sale gain/loss | 18M USD | Medium |
| 2024/08/31 | Asset impairment | Impairment | -4M USD | Medium |
| 2023/08/31 | Asset impairment | Impairment | -41M USD | Medium |
| 2022/08/31 | Asset impairment | Impairment | -152M USD | Medium |
| 2021/08/31 | Business sale gain/loss | Asset sale gain/loss | -5M USD | Medium |
| 2020/08/31 | Asset impairment | Impairment | -13M USD | Medium |
| 2020/08/31 | Business sale gain/loss | Asset sale gain/loss | -16M USD | Medium |
| 2024/05/31 | Asset impairment | Impairment | -970K USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/08/31 | Annual | - | 597M USD | 579M USD | 726M USD | 15.55 | 15.07 |
| 2024/08/31 | Annual | - | 537M USD | 541M USD | 700M USD | 13.91 | 14.01 |
| 2023/08/31 | Annual | - | 468M USD | 509M USD | 585M USD | 12.04 | 13.09 |
| 2022/08/31 | Annual | - | 397M USD | 549M USD | 487M USD | 10.25 | 14.18 |
| 2021/08/31 | Annual | - | 400M USD | 405M USD | 494M USD | 10.36 | 10.49 |
Profit after costs, expenses, interest, and taxes.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.